Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Trooper who wrote (16989)	12/16/1998 7:34:00 AM
From: bazan	Read Replies (2) \| Respond to of 23519

I can't believe this, please someone verify. Schwab has the current bid/ask of 2 5/8-11/16 vol 63,500. Tell me it ain't so!!!

To: Trooper who wrote (16989)	12/16/1998 9:23:00 AM
From: Mkilloran	Respond to of 23519

Trooper...Vivus is working on Gene Therapy for ED. Testing is being done by Dr George Christ at the Albert Einstein Medical Center in NYC. The initial work on mice has been very encouraging. One paper has been published todate by Dr Christ and we are expecting more details in the 1st qtr 99. Dais has posted details of this work on this board ....he is the best one to speak in detail on the details . The basic info is that they are looking at a treatment 3-4 times a year to prevent ED. Could be a very big deal and could be used as an alternative to Viagra and other ED medications. It may be 5 years off in the future....if all works out.